Here's Why Moderna Stock Dropped Wednesday_老虎社区_美港股上老虎

Here's Why Moderna Stock Dropped Wednesday

Motley Fool2021-10-07

The vaccine maker could lose a key portion of its addressable market. What happened Shares of Moderna, Inc. fell 9% on Wednesday after Scandinavian health officials said they would take action to ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

KHYAP
·2021-10-07
🤞🏼
回复
1
举报
MuppyKoh
·2021-10-07
Please like
回复
1
举报
Wins888
·2021-10-07
got for novavax
回复
2
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1151077760?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-10-07 17:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1151077760","market":"us","top_or_hot":-1,"title":"Here's Why Moderna Stock Dropped Wednesday","media":"Motley Fool","content":"<div>\n<p>The vaccine maker could lose a key portion of its addressable market.\n\nWhat happened\nShares of Moderna, Inc. fell 9% on Wednesday after Scandinavian health officials said they would take action to ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/06/heres-why-moderna-stock-dropped-today/\">网页链接</a>\n\n</div>\n","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's Why Moderna Stock Dropped Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's Why Moderna Stock Dropped Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-07 17:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/06/heres-why-moderna-stock-dropped-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The vaccine maker could lose a key portion of its addressable market.\n\nWhat happened\nShares of Moderna, Inc. fell 9% on Wednesday after Scandinavian health officials said they would take action to ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/06/heres-why-moderna-stock-dropped-today/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRNA","symbol_name":"Moderna, Inc.","start_time":0,"source_url":"https://www.fool.com/investing/2021/10/06/heres-why-moderna-stock-dropped-today/","article_id":"1151077760","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1151077760","pubTimestamp":1633597276,"columns":[],"sourceInfo":null,"weMediaInfo":null,"summary":"The vaccine maker could lose a key portion of its addressable market.\n\nWhat happened\nShares of Moder","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRNA":"Moderna, Inc."},"translate_title":"这就是莫德纳股票周三下跌的原因","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":0.9},"content_text":"The vaccine maker could lose a key portion of its addressable market.\n\nWhat happened\nShares of Moderna, Inc. fell 9% on Wednesday after Scandinavian health officials said they would take action to limit the use of the drugmaker's COVID-19 vaccine in children and young adults.\nSo what\nThe Swedish health agency will hold off giving Moderna's drug to people under 30 years old after preliminary data from a not-yet-published study showed a potential higher risk of heart inflammation in those who received the vaccine. \"The connection is especially clear when it comes to Moderna's vaccine Spikevax, especially after the second dose,\" the agency said. Swedish health officials did, however, note that the condition was very rare.\nDenmark will likewise suspend the administration of Moderna's vaccine in kids aged 12 to 17.\nIn its place, the two countries will recommendPfizer (NYSE:PFE)andBioNTech's(NASDAQ:BNTX)COVID-19 vaccine. Additionally, Norway reiterated its recommendation that children and young men use Pfizer and BioNTech's drug due to side effects from Moderna that appear to be more prevalent in young males:\n\"Men under the age of 30 should also consider choosing Cominarty when they get vaccinated,\" Norwegian health official Geir Bukholm said.\nNow what\nIt's not good news when medical professionals recommend a rival's drug in place of your own. But Moderna'sinvestorsshould note that more data from the aforementioned Nordic study is expected in the coming month. The European Medicines Agency (EMA) will review the data to see if additional -- or, perhaps, fewer -- precautions are warranted.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":823115808,"gmtCreate":1633598218762,"gmtModify":1633598289981,"author":{"id":"3562150941808297","authorId":"3562150941808297","name":"KHYAP","avatar":"https://static.tigerbbs.com/134bef1736613cccadcb5091adcc32aa","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3562150941808297","authorIdStr":"3562150941808297"},"htmlText":"🤞🏼","listText":"🤞🏼","text":"🤞🏼","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/823115808","repostId":1151077760,"repostType":4,"repost":{"id":"1151077760","kind":"news","pubTimestamp":1633597276,"share":"https://www.laohu8.com/m/news/1151077760?lang=&edition=full","pubTime":"2021-10-07 17:01","market":"us","language":"en","title":"Here's Why Moderna Stock Dropped Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1151077760","media":"Motley Fool","summary":"The vaccine maker could lose a key portion of its addressable market.\n\nWhat happened\nShares of Moder","content":"<blockquote>\n <b>The vaccine maker could lose a key portion of its addressable market.</b>\n</blockquote>\n<p><b>What happened</b></p>\n<p>Shares of&nbsp;<b><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a>&nbsp;</b>fell 9% on Wednesday after Scandinavian health officials said they would take action to limit the use of the drugmaker's COVID-19 vaccine in children and young adults.</p>\n<p><b>So what</b></p>\n<p>The Swedish health agency will hold off giving Moderna's drug to people under 30 years old after preliminary data from a not-yet-published study showed a potential higher risk of heart inflammation in those who received the vaccine. \"The connection is especially clear when it comes to Moderna's vaccine Spikevax, especially after the second dose,\" the agency said. Swedish health officials did, however, note that the condition was very rare.</p>\n<p>Denmark will likewise suspend the administration of Moderna's vaccine in kids aged 12 to 17.</p>\n<p>In its place, the two countries will recommend<b>Pfizer</b>&nbsp;(NYSE:PFE)and<b>BioNTech</b>'s(NASDAQ:BNTX)COVID-19 vaccine. Additionally, Norway reiterated its recommendation that children and young men use Pfizer and BioNTech's drug due to side effects from Moderna that appear to be more prevalent in young males:</p>\n<p>\"Men under the age of 30 should also consider choosing Cominarty when they get vaccinated,\" Norwegian health official Geir Bukholm said.</p>\n<p><b>Now what</b></p>\n<p>It's not good news when medical professionals recommend a rival's drug in place of your own. But Moderna'sinvestorsshould note that more data from the aforementioned Nordic study is expected in the coming month. The European Medicines Agency (EMA) will review the data to see if additional -- or, perhaps, fewer -- precautions are warranted.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's Why Moderna Stock Dropped Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's Why Moderna Stock Dropped Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-07 17:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/06/heres-why-moderna-stock-dropped-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The vaccine maker could lose a key portion of its addressable market.\n\nWhat happened\nShares of Moderna, Inc. fell 9% on Wednesday after Scandinavian health officials said they would take action to ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/06/heres-why-moderna-stock-dropped-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.fool.com/investing/2021/10/06/heres-why-moderna-stock-dropped-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151077760","content_text":"The vaccine maker could lose a key portion of its addressable market.\n\nWhat happened\nShares of Moderna, Inc. fell 9% on Wednesday after Scandinavian health officials said they would take action to limit the use of the drugmaker's COVID-19 vaccine in children and young adults.\nSo what\nThe Swedish health agency will hold off giving Moderna's drug to people under 30 years old after preliminary data from a not-yet-published study showed a potential higher risk of heart inflammation in those who received the vaccine. \"The connection is especially clear when it comes to Moderna's vaccine Spikevax, especially after the second dose,\" the agency said. Swedish health officials did, however, note that the condition was very rare.\nDenmark will likewise suspend the administration of Moderna's vaccine in kids aged 12 to 17.\nIn its place, the two countries will recommendPfizer (NYSE:PFE)andBioNTech's(NASDAQ:BNTX)COVID-19 vaccine. Additionally, Norway reiterated its recommendation that children and young men use Pfizer and BioNTech's drug due to side effects from Moderna that appear to be more prevalent in young males:\n\"Men under the age of 30 should also consider choosing Cominarty when they get vaccinated,\" Norwegian health official Geir Bukholm said.\nNow what\nIt's not good news when medical professionals recommend a rival's drug in place of your own. But Moderna'sinvestorsshould note that more data from the aforementioned Nordic study is expected in the coming month. The European Medicines Agency (EMA) will review the data to see if additional -- or, perhaps, fewer -- precautions are warranted.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":823118498,"gmtCreate":1633597881378,"gmtModify":1633597881776,"author":{"id":"3585354270249282","authorId":"3585354270249282","name":"MuppyKoh","avatar":"https://static.tigerbbs.com/280b63f52e5976fb134c31bfb22ec07d","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3585354270249282","authorIdStr":"3585354270249282"},"htmlText":"Please like","listText":"Please like","text":"Please like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/823118498","repostId":1151077760,"repostType":4,"repost":{"id":"1151077760","kind":"news","pubTimestamp":1633597276,"share":"https://www.laohu8.com/m/news/1151077760?lang=&edition=full","pubTime":"2021-10-07 17:01","market":"us","language":"en","title":"Here's Why Moderna Stock Dropped Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1151077760","media":"Motley Fool","summary":"The vaccine maker could lose a key portion of its addressable market.\n\nWhat happened\nShares of Moder","content":"<blockquote>\n <b>The vaccine maker could lose a key portion of its addressable market.</b>\n</blockquote>\n<p><b>What happened</b></p>\n<p>Shares of&nbsp;<b><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a>&nbsp;</b>fell 9% on Wednesday after Scandinavian health officials said they would take action to limit the use of the drugmaker's COVID-19 vaccine in children and young adults.</p>\n<p><b>So what</b></p>\n<p>The Swedish health agency will hold off giving Moderna's drug to people under 30 years old after preliminary data from a not-yet-published study showed a potential higher risk of heart inflammation in those who received the vaccine. \"The connection is especially clear when it comes to Moderna's vaccine Spikevax, especially after the second dose,\" the agency said. Swedish health officials did, however, note that the condition was very rare.</p>\n<p>Denmark will likewise suspend the administration of Moderna's vaccine in kids aged 12 to 17.</p>\n<p>In its place, the two countries will recommend<b>Pfizer</b>&nbsp;(NYSE:PFE)and<b>BioNTech</b>'s(NASDAQ:BNTX)COVID-19 vaccine. Additionally, Norway reiterated its recommendation that children and young men use Pfizer and BioNTech's drug due to side effects from Moderna that appear to be more prevalent in young males:</p>\n<p>\"Men under the age of 30 should also consider choosing Cominarty when they get vaccinated,\" Norwegian health official Geir Bukholm said.</p>\n<p><b>Now what</b></p>\n<p>It's not good news when medical professionals recommend a rival's drug in place of your own. But Moderna'sinvestorsshould note that more data from the aforementioned Nordic study is expected in the coming month. The European Medicines Agency (EMA) will review the data to see if additional -- or, perhaps, fewer -- precautions are warranted.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's Why Moderna Stock Dropped Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's Why Moderna Stock Dropped Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-07 17:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/06/heres-why-moderna-stock-dropped-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The vaccine maker could lose a key portion of its addressable market.\n\nWhat happened\nShares of Moderna, Inc. fell 9% on Wednesday after Scandinavian health officials said they would take action to ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/06/heres-why-moderna-stock-dropped-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.fool.com/investing/2021/10/06/heres-why-moderna-stock-dropped-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151077760","content_text":"The vaccine maker could lose a key portion of its addressable market.\n\nWhat happened\nShares of Moderna, Inc. fell 9% on Wednesday after Scandinavian health officials said they would take action to limit the use of the drugmaker's COVID-19 vaccine in children and young adults.\nSo what\nThe Swedish health agency will hold off giving Moderna's drug to people under 30 years old after preliminary data from a not-yet-published study showed a potential higher risk of heart inflammation in those who received the vaccine. \"The connection is especially clear when it comes to Moderna's vaccine Spikevax, especially after the second dose,\" the agency said. Swedish health officials did, however, note that the condition was very rare.\nDenmark will likewise suspend the administration of Moderna's vaccine in kids aged 12 to 17.\nIn its place, the two countries will recommendPfizer (NYSE:PFE)andBioNTech's(NASDAQ:BNTX)COVID-19 vaccine. Additionally, Norway reiterated its recommendation that children and young men use Pfizer and BioNTech's drug due to side effects from Moderna that appear to be more prevalent in young males:\n\"Men under the age of 30 should also consider choosing Cominarty when they get vaccinated,\" Norwegian health official Geir Bukholm said.\nNow what\nIt's not good news when medical professionals recommend a rival's drug in place of your own. But Moderna'sinvestorsshould note that more data from the aforementioned Nordic study is expected in the coming month. The European Medicines Agency (EMA) will review the data to see if additional -- or, perhaps, fewer -- precautions are warranted.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":823110409,"gmtCreate":1633597438646,"gmtModify":1633597438854,"author":{"id":"3573623994106312","authorId":"3573623994106312","name":"Wins888","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3573623994106312","authorIdStr":"3573623994106312"},"htmlText":"got for novavax","listText":"got for novavax","text":"got for novavax","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/823110409","repostId":1151077760,"repostType":4,"repost":{"id":"1151077760","kind":"news","pubTimestamp":1633597276,"share":"https://www.laohu8.com/m/news/1151077760?lang=&edition=full","pubTime":"2021-10-07 17:01","market":"us","language":"en","title":"Here's Why Moderna Stock Dropped Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1151077760","media":"Motley Fool","summary":"The vaccine maker could lose a key portion of its addressable market.\n\nWhat happened\nShares of Moder","content":"<blockquote>\n <b>The vaccine maker could lose a key portion of its addressable market.</b>\n</blockquote>\n<p><b>What happened</b></p>\n<p>Shares of&nbsp;<b><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a>&nbsp;</b>fell 9% on Wednesday after Scandinavian health officials said they would take action to limit the use of the drugmaker's COVID-19 vaccine in children and young adults.</p>\n<p><b>So what</b></p>\n<p>The Swedish health agency will hold off giving Moderna's drug to people under 30 years old after preliminary data from a not-yet-published study showed a potential higher risk of heart inflammation in those who received the vaccine. \"The connection is especially clear when it comes to Moderna's vaccine Spikevax, especially after the second dose,\" the agency said. Swedish health officials did, however, note that the condition was very rare.</p>\n<p>Denmark will likewise suspend the administration of Moderna's vaccine in kids aged 12 to 17.</p>\n<p>In its place, the two countries will recommend<b>Pfizer</b>&nbsp;(NYSE:PFE)and<b>BioNTech</b>'s(NASDAQ:BNTX)COVID-19 vaccine. Additionally, Norway reiterated its recommendation that children and young men use Pfizer and BioNTech's drug due to side effects from Moderna that appear to be more prevalent in young males:</p>\n<p>\"Men under the age of 30 should also consider choosing Cominarty when they get vaccinated,\" Norwegian health official Geir Bukholm said.</p>\n<p><b>Now what</b></p>\n<p>It's not good news when medical professionals recommend a rival's drug in place of your own. But Moderna'sinvestorsshould note that more data from the aforementioned Nordic study is expected in the coming month. The European Medicines Agency (EMA) will review the data to see if additional -- or, perhaps, fewer -- precautions are warranted.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's Why Moderna Stock Dropped Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's Why Moderna Stock Dropped Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-07 17:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/06/heres-why-moderna-stock-dropped-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The vaccine maker could lose a key portion of its addressable market.\n\nWhat happened\nShares of Moderna, Inc. fell 9% on Wednesday after Scandinavian health officials said they would take action to ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/06/heres-why-moderna-stock-dropped-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.fool.com/investing/2021/10/06/heres-why-moderna-stock-dropped-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151077760","content_text":"The vaccine maker could lose a key portion of its addressable market.\n\nWhat happened\nShares of Moderna, Inc. fell 9% on Wednesday after Scandinavian health officials said they would take action to limit the use of the drugmaker's COVID-19 vaccine in children and young adults.\nSo what\nThe Swedish health agency will hold off giving Moderna's drug to people under 30 years old after preliminary data from a not-yet-published study showed a potential higher risk of heart inflammation in those who received the vaccine. \"The connection is especially clear when it comes to Moderna's vaccine Spikevax, especially after the second dose,\" the agency said. Swedish health officials did, however, note that the condition was very rare.\nDenmark will likewise suspend the administration of Moderna's vaccine in kids aged 12 to 17.\nIn its place, the two countries will recommendPfizer (NYSE:PFE)andBioNTech's(NASDAQ:BNTX)COVID-19 vaccine. Additionally, Norway reiterated its recommendation that children and young men use Pfizer and BioNTech's drug due to side effects from Moderna that appear to be more prevalent in young males:\n\"Men under the age of 30 should also consider choosing Cominarty when they get vaccinated,\" Norwegian health official Geir Bukholm said.\nNow what\nIt's not good news when medical professionals recommend a rival's drug in place of your own. But Moderna'sinvestorsshould note that more data from the aforementioned Nordic study is expected in the coming month. The European Medicines Agency (EMA) will review the data to see if additional -- or, perhaps, fewer -- precautions are warranted.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":15,"commentSize":3,"repostSize":0,"favoriteSize":1,"likeStatus":false,"favoriteStatus":false}}